Xtrackers FTSE 100 Short Daily Swap UCITS ETF 1C

INVESTMENT OBJECTIVE: The aim is for your investment to track the performance of the FTSE 100 Daily Short Index (index) which provides the opposite performance of the FTSE 100 Total Return Declared Dividend Index (Underlying Index) on a daily basis plus a rate of interest and minus borrowing costs. This means that the level of the index should rise when the Underlying Index falls and fall when the Underlying Index rises on a daily basis. The interest rate added to the index level is based on double the rate at which banks in London lend to each other on an overnight basis (as reported to the Bank of England). DESCRIPTION OF INDEX: The Underlying Index reflects the performance of the shares of the largest 100 UK companies listed on the London Stock Exchange. The companies are selected on the basis that they have the largest combined value of shares as compared to other companies on the stock exchange. INDEX REBALANCING, CALCULATION AND ADMINISTRATION: The index is administered by FTSE International Limited. The index is calculated on a gross total return basis which means that all dividends and distributions are reinvested in the shares. The composition of the Underlying Index is reviewed quarterly. INVESTMENT POLICY:To achieve the aim, the fund will enter into financial contracts (derivatives) with one or more swap counterparties to swap most subscription proceeds for the return on the index. FURTHER INFORMATION: Certain information (including the latest share prices of the fund, indicative net asset values, full disclosure on the composition of the fund's portfolio and information on the index constituents) are available on your local DWS website or at www.Xtrackers.com. Transaction costs and taxes, unexpected fund costs and market conditions such as volatility or liquidity issues may affect the ability of the fund to track the index. The anticipated level of tracking error in normal market conditions is 1 per cent. The return of the product is reflected by the d

Synthetic replication - fully funded swap backed by collateral

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No